iSPAAC: Isomer-Free Generation of a Bcl-xL -Inhibitor in Living Cells

Chemistry. 2018 Sep 18;24(52):13762-13766. doi: 10.1002/chem.201803032. Epub 2018 Aug 20.

Abstract

Strain-promoted azide-alkyne cycloadditions (SPAAC) have proven extremely useful for labeling of biomolecules, but typically produce isomeric mixtures. This is not appropriate for the formation of bioactive molecules in living cells. Here, the first use of SPAAC for the isomer-free synthesis of a bioactive molecule is reported both in vitro and inside cultured cells. We developed the symmetrical cyclooctyne SYPCO and used it for the generation of a chemically uniform triazole inhibitor of protein-protein interactions mediated by Bcl-xL via isomer-free SPAAC (iSPAAC). Tumor cells treated with the reactants of the iSPAAC reaction contained higher concentrations of triazole, and displayed higher apoptosis levels, than cells treated with pre-synthesized triazole. We envision iSPAAC as a broadly applicable method for modulating intracellular targets with organic molecules with molecular weights prohibitively large for cellular uptake, via smaller and thus more cell-permeable components.

Keywords: apoptosis; bioorthogonal chemistry; cyclooctynes; inhibitors; protein-protein interactions.

MeSH terms

  • Alkynes / chemistry
  • Alkynes / pharmacology
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology
  • Apoptosis
  • Azides / chemistry
  • Azides / pharmacology
  • Cycloaddition Reaction
  • Humans
  • Isomerism
  • K562 Cells
  • Kinetics
  • Molecular Docking Simulation
  • Molecular Weight
  • Protein Binding
  • Triazoles / chemical synthesis*
  • Triazoles / pharmacology
  • bcl-X Protein / antagonists & inhibitors*

Substances

  • Alkynes
  • Antineoplastic Agents
  • Azides
  • Triazoles
  • bcl-X Protein